23076-35-9 Veterinary API 99% Xylazine Hydrochloride Raw Crystalline Powder

Basic Information
Place of Origin: China
Brand Name: HNB
Certification: ISO
Model Number: Xylazine Hydrochloride
Minimum Order Quantity: 1KG
Price: Negotiable
Packaging Details: Aluminum foil bag
Delivery Time: Usually3-5days
Payment Terms: L/C, D/A, D/P, T/T, Western Union, MoneyGram,Alibaba Assurance Order
Supply Ability: 5000kg/Month
Detail Information
CAS: 23076-35-9 Mf: C12H17ClN2S
MW: 256.8 Specification: 99%
Grade: Medicine Grade Appearance: White Crystalline Powder
Sample: Available
High Light:

Raw Xylazine Hydrochloride Powder


API Xylazine Hydrochloride


Medicine Grade Xylazine Hydrochloride

Product Description

23076-35-9 Veterinary API 99% Xylazine Hydrochloride Raw Crystalline Powder

23076-35-9 Veterinary API 99% Xylazine Hydrochloride Raw Crystalline Powder 0

Product name

Xylazine Hydrochloride


White crystalline powder








Keep in cool dry place.

23076-35-9 Veterinary API 99% Xylazine Hydrochloride Raw Crystalline Powder 1


The Introductction of Xylazine Hydrochloride


Xylazine HCl is an alpha2-adrenergic receptor agonist used as a tranquilizer and muscle relaxant.


Xylazine Hydrochloride is a sedative veterinary drug. It can cause mild inhibition of the central nervous system, weakening the functional activities, so as to eliminate restlessness and restoration of quiet class of drugs. In recent years, individual livestock breeders driven by economic interests, unauthorized in the process of raising livestock and poultry to add such drugs to play a sedative hypnotic, weight gain and fattening, shorten the role of slaughter time; in addition, in the process of animal transportation, in order to reduce animal death and weight loss, to prevent the reduction of meat quality, also often use such drugs to reduce the loss of stress.


Xylazine Hydrochloride in vivo study

Xylazine (5.2 mg/kg; intraperitoneal injection; for 10-60 minutes; male Sprague-Dawley rats) administration alters mRNA expression and protein phosphorylation levels of AMPK signaling molecules, suggesting that the LKB1-AMPK pathway plays a role in the sedative and tranquilizing effects in the CNS caused by Xylazine treatment.

Animal Model: Male Sprague-Dawley rats (160-180 g)[
Dosage: 5.2 mg/kg
Administration: Intraperitoneal injection; for 10 minutes, 20 minutes, 40 minutes or 60 minutes
Result: Increased in AMPK activity in the cerebral cortex, hippocampus, thalamus and cerebellum. Phosphorylated LKB1 and AMPKα protein levels were decreased.



Adverse reactions and side effects

Xylazine Hydrochloride is used as an alpha2-adrenoceptor agonist, sedative and muscle relaxant.



Other Name of Xylazine Hydrochloride:








The COA of Xylazine Hydrochloride


Batch Number: HNB2020106

Batch Quantity: 120kg
Manufacture Date: May.06,2022 Analysis Date: May.07,202 



Storage:Store in cool & dry place. Store in well-closed containers.
Shelf life:2 years when properly stored.









Assay(Dry base by HPLC) 98%~102% 99.82%
Appearance White or almost white crystalline powder Complies
Identification A: IR absorption Complies
B: the Thin-layer chromatographic identification test Complies
Melting range 164℃~168℃ 164.5℃~166.4℃
pH 4.0~6.0 5.09
Residue on Ignition ≤0.1% 0.08%
Loss on drying ≤1.0% 0.12%
Total Heavy Metals ≤20ppm Complies
Chromatographic purity Total impurities≤2.0% Complies
Conclusion Conforms with the Standard

Contact Details
Beryl Jia

Phone Number : +8618092068319

WhatsApp : +8618629242069